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Abstract
The patient was an 84-year-old woman who had the onset of truncal ataxia at age 77 and a history of Basedow’s
disease. Her ataxic gait gradually deteriorated. She could not walk without support at age 81 and she was
admitted to our hospital at age 83. Gaze-evoked nystagmus and dysarthria were observed. Mild ataxia was
observed in all limbs. Her deep tendon reflex and sense of position were normal. IgA anti-gliadin antibody, IgG
anti-gliadin antibody, anti-SS-A/Ro antibody, anti-SS-B/La antibody and anti-TPO antibody were positive. A
conventional brain MRI did not show obvious cerebellar atrophy. However, MRI voxel based morphometry (VBM)
and SPECT-eZIS revealed cortical cerebellar atrophy and reduced cerebellar blood flow. IVIg treatment was
performed and was moderately effective. After her death at age 85, the patient was autopsied. Neuropathological
findings were as follows: selective loss of Purkinje cells; no apparent degenerative change in the efferent pathways,
such as the dentate nuclei or vestibular nuclei; no prominent inflammatory reaction. From these findings, we
diagnosed this case as autoimmune cerebellar atrophy associated with gluten ataxia. All 3 autopsies previously
reported on gluten ataxia have noted infiltration of inflammatory cells in the cerebellum.
In this case, we postulated that the infiltration of inflammatory cells was not found because the patient’s condition
was based on humoral immunity. The clinical conditions of gluten ataxia have not yet been properly elucidated,
but are expected to be revealed as the number of autopsied cases increases.
Background
It has recently been reported that autoimmune cerebel-
lar ataxias, such as gluten ataxia [1] and anti-glutamic
acid decarboxylase (GAD)-antibody-positive cerebellar
ataxia [2-4], are treatable. However, because of the small
number of previous autopsy reports, the neuropathology
and clinical conditions of autoimmune cerebellar ataxia
are yet to be determined.
We experienced the case of an elderly woman who
was suspected of autoimmune cerebellar ataxia asso-
ciated with gluten ataxia due to the presence of IgG and
IgA anti-gliadin antibody positivity and a positive
response to high-dose immunoglobulin therapy. How-
ever, it was difficult to diagnose whether she had cere-
bellar atrophy or not.
The autopsy after her death at 85 showed selective
loss of Purkinje cells and a diagnosis of autoimmune
cerebellar atrophy was confirmed. However, the patholo-
gical findings differed to previous reports of gluten
ataxia. Thus we present our own report with considera-
tion of the clinical features.
Case Presentation
The patient was an 84-year-old woman who had the
onset of truncal ataxia at age 77 and had a history of
Basedow’s disease. There was nothing significant in her
family history. Her ataxic gait gradually deteriorated. At
a g e8 1 ,s h ec o u l dn o tw a l kw i t h o u ts u p p o r t .A ta g e8 3 ,
she was admitted to our hospital. Gaze-evoked nystag-
mus and dysarthria were observed. The patient showed
a wide-based gait and she required assistance to walk.
Mild ataxia was observed in all limbs. Her deep tendon
reflex and sense of position were normal. Her antibody
levels were as follows: rheumatoid factor, 21 IU/mL
(normal < 18 IU/mL); anti-SS-A/Ro antibody, >500 U/
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mL (normal < 10 U/mL); anti-TPO antibody, 1.0 U/mL;
IgA anti-gliadin antibody, 42.7 EU (normal < 20 EU);
and IgG anti-gliadin antibody, 21.9 EU (normal < 20
EU). Anti-Hu, anti-Yo and anti-GAD antibodies were all
negative. A conventional brain MRI showed mild cere-
bellar atrophy, which seemed to be consistent with age
(Figure 1). However, MRI voxel based morphometry
(VBM) and SPECT-eZIS revealed cortical cerebellar
atrophy and reduced cerebellar blood flow (Figure 2,
Figure 3). A nerve conduction test was within the nor-
mal range. Cerebrospinal fluid examination showed a
normal cell count, and the protein concentration was 40
mg/dL.
IVIg treatments were performed twice with an interval
of 6 months between them, and her ICARS score
improved from 31 to 22 at the first therapy and from 33
to 23 at the second therapy, indicating that IVIg therapy
was moderately effective. After the IVIg treatment, the
anti-TPO antibody level became negative, the anti-SS-A/
Ro antibody level decreased to 391 U/mL, and the anti-
SS-B/La antibody level decreased to 7.3 U/mL. The IgA
anti-gliadin antibody level decreased to 3.7 EU. The
p a t i e n td i e di nh e rn u r s i n gh o m ea ta g e8 5 .T h ec a u s e
of death was not clear, but aspiration pneumonia was
suspected and an autopsy was performed.
The autopsy was performed 24-hours after her death,
and a localized lung abscess with Aspergillus infection
was found. Marked atrophy of the thyroid gland was
discerned, chronic inflammatory cell infiltration or folli-
cular epithelial changes were not seen, and hyperplastic
findings were not obvious. Severe atrophic changes in
the salivary glands with lymphoid cell infiltration were
also seen in association with Sjögren’s syndrome. The
digestive system exhibited severe post-mortem autolysis.
Although precise histological examination could not be
made, flattening, blunting, atrophy, disappearance or
other findings related to the celiac disease were not
obvious. In addition, benigno rm a l i g n a n tt u m o r sw e r e
not found.
A proportion of the cerebrum appeared to have been
preserved. No prominent atrophic changes were identi-
fied and this included the hippocampus. Minimal cere-
bellar atrophy might have been present, but no atrophic
change was discerned in the brain stem.
Histologically, the thickness of the molecular layer of
the cerebellum appeared to have been preserved, but a
mild thinning of the granular layers was observed. A
mild to moderate decrease in the number of Purkinje
cells was observed in association with mild Bergman
gliosis elsewhere in the cerebellar cortex (Figure 4).
Mild accentuation in the vermis and in the bottom of
the cerebellar folia was noted. Empty basket cells were
occasionally seen. Edematous splitting of the Purkinje
cell layers was also noted. No apparent inflammatory
cell reaction was identified after immunostaining for
CD3, CD4, CD8, CD20, CD68 or CD79a. The dentate
nucleus was preserved without apparent neuronal loss
or gliosis, as were the inferior olivary nuclei and the
Figure 1 Brain MRI. Conventional brain MRI showed mild
cerebellar atrophy, which seemed to be consistent with age.
Figure 2 MRI voxel based morphometry. MRI voxel based
morphometry revealed cortical cerebellar atrophy, which was left
hemisphere dominant.
Figure 3 SPECT-eZIS. SPECT-eZIS revealed reduced cerebellar
blood flow, which was left hemisphere dominant.
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spinal cord was also preserved.
To summarize the neuropathological findings, selec-
tive loss of the Purkinje cells was found and there was
no apparent degenerative change in the efferent path-
ways, such as the dentate nuclei or the vestibular nuclei.
No prominent inflammatory reaction was identified.
Discussion
In this patient, the culprit lesion of truncal ataxia was
not determined until 7 years after onset of the diseases.
During the 7 intervening years, neither clinical nor neu-
rophysiological examinations had demonstrated any
findings indicative of peripheral nerve disorder, and con-
ventional MRI had also provided no distinct finding of
cerebellar atrophy. Seven years after onset of the disease,
SPECT revealed slight reduction in blood flow in the
cerebellum, which was left hemisphere dominant, and
the images of MRI voxel-based morphometry demon-
strated atrophy of the cerebellar cortex in the same
area. Although the diagnosis was difficult to establish,
cortical cerebellar atrophy was suspected. In addition,
autoimmune cerebellar ataxia was suspected based on
positive gliadin and thyroid antibodies and therefore the
treatment with IVIg and steroid therapy was performed,
leading to amelioration of truncal ataxia. Eight years
after disease onset, the patient died and an autopsy was
performed. The autopsy showed that the number of
Purkinje cells in the cerebellum was moderately
decreased in a selective manner. Consequently, the cere-
bellum was found to be the location of the culprit lesion
causing truncal ataxia in the patient, leading to a defini-
tive diagnosis of cortical cerebellar atrophy.
Moreover, prior to death, the patient had positive
anti-SS-A and anti-SS-B antibodies without drying
symptoms and was not thus diagnosed as having Sjög-
ren syndrome. However, infiltration of lymphocytes as
w e l la sad e c r e a s ei nt h en u m b e ro fa c i n ii nt h es u b -
mandibular gland was found at autopsy. This led to the
diagnosis of Sjögren syndrome.
In this patient, autoimmune cerebellar ataxia was sus-
pected, given the findings of positive IgG and IgA anti-
bodies to gliadin, positive anti-SS-A and anti-SS-B
antibodies, and positive thyroid antibody, as well as the
previous history of Basedow disease. Consequently, the
treatment with intravenous immunogloblin and steroid
therapy was performed, resulting in amelioration of
truncal ataxia. A large number of reports on autoim-
mune cerebellar ataxia have been accumulated, includ-
ing gluten ataxia [1], anti-GAD-antibody-positive
cerebellar ataxia [2-4], Hashimoto encephalopathy [5,6],
Sjögren syndrome [7], and neuro-Behçet disease [8].
This patient was diagnosed as having autoimmune cere-
bellar ataxia close to gluten ataxia because the patient
had simple cortical cerebellar atrophy. This diagnosis
was also appropriate given the lack of autopsy findings
indicative of hereditary spinocerebellar degeneration
such as SCA3 and SCA6 and multiple system atrophy,
and because several types of autoantibodies [9] were
found that have been reported previously in association
with autoimmune cerebellar ataxia, including anti-glia-
din antibody.
Gluten ataxia patients are known to be positive for
anti-gliadin antibody. Hadjibassiliou et al. reported that
anti-gliadin antibody cross-reacts with epitopes on Pur-
kinje cells from human and rat cerebellum, and in doing
so strengthens the impact of circulating antibodies
against cerebellar Purkinje cells [10]. Hadjibassiliou et
al. also reported post-mortem findings from two
patients with gluten ataxia. Examination of the central
nervous system revealed patchy loss of Purkinje cells
throughout the cerebellar cortex. The cerebellar white
matter showed astrocytic gliosis, and a diffuse infiltrate
of mainly T-lymphocytes. Substantial perivascular cuff-
ing with inflammatory cells, mainly T lymphocytes with
smaller numbers of B lymphocytes and macrophages,
was present within the cerebellar white matter and the
posterior columns of the spinal cord [11]. In addition,
Mittelbronn et al. reported that examination of the cere-
bellum of a 68-year-old male with gluten ataxia showed
a na b s e n c eo fB -o rp l a s m ac e l l sb u tm u l t i p l eC D 8
+,
suggesting that there are prominent cytotoxic effects in
the neuropathogenesis of gluten ataxia [12]. The patho-
logical findings of gluten ataxia in these reports differ
from our case in that they show infiltration of inflam-
matory cells in the cerebellum. As described above, the
pathological findings reported previously with gluten
Figure 4 Selective loss of Purkinje cells. Histologically, the
thickness of the molecular layer of the cerebellum appears to be
preserved, but a mild thinning of the granular layers was observed.
A mild to moderate decrease in the number of the Purkinje cells
was observed in association with mild Bergman gliosis.
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cerebellum, which was not observed in our patient.
Along with gluten ataxia, paraneoplastic cerebellar
ataxia and anti-GAD-antibody-positive cerebellar ataxia
cause autoimmune damage to Purkinje cells in the cere-
bellum. A large number of autopsied cases of paraneo-
plastic cerebellar ataxia have been reported, but often
without findings of inflammatory reactions. In the
pathological investigation of three patients complicated
with paraneoplastic cerebellar ataxia and LEMS, Fukuda
et al. reported that a loss of Purkinje cells in the
cerebellum was evident but HE staining and immunos-
taining using CD3, CD4, CD19, and CD20 did not
demonstrate infiltration of lymphocytes in the cerebellar
cortex [13]. Ishida et al. have also reported in an autop-
sied case of anti-GAD-antibody-positive cerebellar ataxia
that near-complete depression of the Purkinje cells was
observed without infiltration of inflammatory cells [14].
As stated above, only a few autopsies of gluten ataxia
have been previously reported, however in both cases,
immune therapy was not confirmed to be effective. We
considered the diagnosis of autoimmune cerebellar
ataxia possible in this case for the following reasons:
immune therapy was effective; anti-gliadin antibody,
anti-thyroid antibody and anti-SS-A antibody that are
suggested to be related to autoimmune cerebellar ataxia
were present; the patient’sh i s t o r yo fB a s e d o w ’s disease;
and the definite diagnosis of Sjögren’ss y n d r o m eo n
autopsy. In the event that immune cerebellar neural dis-
orders are preceded by humoral immunity, the patholo-
gical finding of poor infiltration of inflammatory cells, as
found in this case and in some paraneoplastic
syndromes can be explained. In this case, the adminis-
tering of immune therapies including 2 instances of
high-dose immunoglobulin therapy and steroid therapy
might have affected the pathological findings.
Although antemortem diagnosis was difficult in the
patient’s life time, the loss of Purkinje cells that was found
on autopsy led to the diagnosis of autoimmune cerebellar
atrophy. Where this case differs from others that have
been previously reported is in the atypical pathological
finding of an absence of an inflammatory response. In the
future we can expect an accumulation of autopsy cases
and clarification of the corresponding pathological condi-
tions, and this should provide more information on cases
of autoimmune cerebellar ataxia, including gluten ataxia
and anti-GAD-antibody-positive cerebellar ataxia.
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